The US Senate has passed the FDA Modernization Act with unanimous consent!
A massive stride in the acceptance of alternatives to animal models in drug discovery. Alternatives that capture human physiology better, that are more ethical, sustainable and most importantly, alternatives that can accelerate the discovery of life changing therapies. Alternatives that our bioprinters have proudly supported and enabled since our inception. Alternatives that we are committed to continuing to develop and democratize.
Learn more
Attachments
-
Original Link
-
Original Document
-
Permalink
Disclaimer
BICO Group AB published this content on 30 September 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 September 2022 12:13:04 UTC.